These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 14564228)
1. Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide. Gibler WB; Blomkalns AL; Collins SP Rev Cardiovasc Med; 2003; 4 Suppl 4():S47-55. PubMed ID: 14564228 [TBL] [Abstract][Full Text] [Related]
2. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes. de Lemos JA; Morrow DA Rev Cardiovasc Med; 2003; 4 Suppl 4():S37-46. PubMed ID: 14564227 [TBL] [Abstract][Full Text] [Related]
3. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome. Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Eggers KM; Oldgren J; Nordenskjöld A; Lindahl B Am Heart J; 2004 Oct; 148(4):574-81. PubMed ID: 15459585 [TBL] [Abstract][Full Text] [Related]
9. Risk stratification for suspected acute coronary syndromes and heart failure in the emergency department. Peacock WF; Soto-Ruiz KM Acute Card Care; 2009; 11(3):138-45. PubMed ID: 19452341 [TBL] [Abstract][Full Text] [Related]
10. The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea. Singer AJ; Thode HC; Green GB; Birkhahn R; Shapiro NI; Cairns C; Baumann BM; Aghababian R; Char D; Hollander JE Acad Emerg Med; 2009 Jun; 16(6):488-94. PubMed ID: 19388909 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of biochemical markers, 12-lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome. Svensson L; Axelsson C; Nordlander R; Herlitz J J Intern Med; 2004 Apr; 255(4):469-77. PubMed ID: 15049881 [TBL] [Abstract][Full Text] [Related]
12. New strategies available for fast chest pain triaging. Clin Resour Manag; 2001 Mar; 2(3):39-41, 33. PubMed ID: 11301581 [TBL] [Abstract][Full Text] [Related]
13. Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Apple FS; Jaffe AS Circulation; 2001 Nov; 104(22):E125-6. PubMed ID: 11723038 [No Abstract] [Full Text] [Related]
14. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain. Kwan G; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL J Am Coll Cardiol; 2007 Mar; 49(11):1186-92. PubMed ID: 17367663 [TBL] [Abstract][Full Text] [Related]
15. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of acute coronary syndrome. Achar SA; Kundu S; Norcross WA Am Fam Physician; 2005 Jul; 72(1):119-26. PubMed ID: 16035692 [TBL] [Abstract][Full Text] [Related]
17. A rapid point-of-care cardiac marker testing strategy facilitates the rapid diagnosis and management of chest pain patients in the emergency department. Straface AL; Myers JH; Kirchick HJ; Blick KE Am J Clin Pathol; 2008 May; 129(5):788-95. PubMed ID: 18426740 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers in acute cardiovascular disease. Howie-Esquivel J; White M J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes. Wiviott SD; de Lemos JA; Morrow DA Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312 [TBL] [Abstract][Full Text] [Related]
20. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study. Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]